title: 2.0 mg Intravitreal aflibercept as therapy for exudative age-related.
authors: Keith
authors: K
authors: Barton
authors: James
authors: J
authors: Chodosh
authors: Jost B
authors: JB
authors: Jonas
mesh_terms: D005122:Exudates and Transudates; D005128:Eye Diseases; D006801:Humans; D058449:Intravitreal Injections; D040262:Receptors, Vascular Endothelial Growth Factor / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D014792:Visual Acuity; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor